BACKGROUND Self-efficacy plays a major role in the management of cardiovascular disease (CVD). The original Cardiovascular Management Self-efficacy Scale (CMSS) was developed in 2016 in Italian patients with CVD; however, no such scale exists for Iranian patients with CVD. OBJECTIVE We translated the CMSS into Persian and assessed its validity, reliability, and psychometric properties in Iranian patients with CVD. METHODS This study was conducted for 4 months in 2017 on a group of consenting patients with CVD (N = 363) recruited from a cardiovascular hospital in Kermanshah, Iran. The reliability of the Persian CMSS was evaluated. We assessed validity, including face, content, construct, convergent, divergent, and discriminate validity, using the General Self-efficacy Scale, the Hospital Anxiety and Depression Scale, and the 36-item Short Form Health Survey Scale. Known-group validity was assessed among patients with high blood pressure. RESULTS The Persian CMSS had acceptable face and content validity. No floor or ceiling effects were found for the total scale. Cronbach α was calculated as .68. Test-retest reliability was confirmed by intraclass correlation coefficient (ICC1,3 = 0.98, P < .001). Using exploratory factor analysis, 3 subscales were identified, similar to the original version. Significant correlations were found between the Persian CMSS and both the General Self-efficacy Scale (r = 0.94, P < .001) and Hospital Anxiety and Depression Scale (r = -0.35, P < .05). Self-efficacy measured using the Persian CMSS was statistically different between 2 levels of patients' health status (P < .05). Patients with hypertension had a lower level of self-efficacy than those in the healthy group (P < .05). CONCLUSIONS The Persian version of CMSS provides a practical, reliable, and valid scale for evaluating self-efficacy in the clinical management of Persian Iranian patients with CVD.

中文翻译：

---

波斯版心血管管理自我效能量表的心理测量学特性。

背景自我效能在心血管疾病(CVD)的管理中起主要作用。最初的心血管管理自我效能量表 (CMSS) 于 2016 年针对意大利 CVD 患者开发；然而，伊朗的 CVD 患者不存在这样的规模。目的 我们将 CMSS 翻译成波斯语，并评估其在伊朗 CVD 患者中的有效性、可靠性和心理测量特性。方法 本研究于 2017 年对一组从伊朗克尔曼沙赫心血管医院招募的 CVD 患者（N = 363）进行了为期 4 个月的研究。波斯 CMSS 的可靠性进行了评估。我们使用一般自我效能感量表、医院焦虑和抑郁量表评估效度，包括面子效度、内容效度、结构效度、收敛效度、发散效度和区分效度，和 36 项简表健康调查量表。在高血压患者中评估已知组效度。结果 波斯 CMSS 具有可接受的表面效度和内容效度。没有发现总规模的地板或天花板效应。Cronbach α 计算为 0.68。重测信度由组内相关系数确认（ICC1,3 = 0.98，P < .001）。使用探索性因素分析，确定了 3 个分量表，与原始版本相似。波斯 CMSS 与一般自我效能感量表 (r = 0.94, P < .001) 和医院焦虑和抑郁量表 (r = -0.35, P < .05) 之间存在显着相关性。使用波斯 CMSS 测量的自我效能在 2 个患者健康状况水平之间存在统计学差异 (P < .05)。高血压患者的自我效能感低于健康组（P < .05）。结论 波斯语版本的 CMSS 提供了一个实用、可靠和有效的量表，用于评估波斯伊朗 CVD 患者临床管理中的自我效能。